PCSK9 immunoassay

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 8748115
SERIAL NO

13139045

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Methods of using PCSK9 antagonists More specifically, methods for measuring circulating PCSK9 levels in a biological sample by means of an immunoassay The immunoassay used can be a solid phase immunoassay, such as a dissociation-enhanced lanthanide fluorescence immunoassay utilizing an E07 capture antibody or coating and a G08 or H23 detecting antibody.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
MERCK & CO INCNEW JERSEY U S A

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Condra, Jon Doylestown, US 3 178
Cubbon, Rose Fanwood, US 4 256
Lewis, Dale Washington Crossing, US 4 109
Lobo, Sharon Hackettstown, US 2 100
McCabe, Timothy Doylestown, US 9 347
Ni, Yan Westfield, US 13 262
Pandit, Shilpa Edison, US 20 1549
Shen, Xun Piscataway, US 3 102
Sitlani, Ayesha Metuchen, US 20 1505

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Dec 10, 2025
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00